InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Kreitzer Anatol. Officer active across 1 company, notably MapLight Therapeutics, Inc.. Cumulatively, 5 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €1.2m. History available since 27 October 2025. The latest transaction was disclosed on 27 April 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Kreitzer Anatol is a declarant linked to MapLight Therapeutics, Inc. He has 4 filings in total, and the 4 most recent sampled filings, from 2026-04-17 to 2026-04-29, concern sales for a total of EUR 1223755.